Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 11 | $2,210,062 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 21 Feb 2025 18:05 | DAWN | Day One Biopharmaceuticals Inc | BENDER JEREMY | CHIEF EXECUTIVE OFFICER | 18 Feb 2025 | Sale | 12,048 | 11.963 | 144,130 | D |
| 19 Nov 2024 16:36 | DAWN | Day One Biopharmaceuticals Inc | BENDER JEREMY | CHIEF EXECUTIVE OFFICER | 18 Nov 2024 | Sale | 10,554 | 13.2102 | 139,420 | D |
| 19 Aug 2024 17:53 | DAWN | Day One Biopharmaceuticals Inc | BENDER JEREMY | CHIEF EXECUTIVE OFFICER | 16 Aug 2024 | Sale | 10,681 | 13.9991 | 149,524 | D |
| 17 May 2024 18:27 | DAWN | Day One Biopharmaceuticals Inc | BENDER JEREMY | CHIEF EXECUTIVE OFFICER | 16 May 2024 | Sale | 7,873 | 16.0787 | 126,588 | D |
| 03 May 2024 18:48 | DAWN | Day One Biopharmaceuticals Inc | BENDER JEREMY | CHIEF EXECUTIVE OFFICER | 02 May 2024 | Sale | 6 | 17.9375 | 108 | D |
| 03 May 2024 18:48 | DAWN | Day One Biopharmaceuticals Inc | BENDER JEREMY | CHIEF EXECUTIVE OFFICER | 03 May 2024 | Sale | 9,154 | 17.852 | 163,417 | D |
| 03 May 2024 18:48 | DAWN | Day One Biopharmaceuticals Inc | BENDER JEREMY | CHIEF EXECUTIVE OFFICER | 01 May 2024 | Sale | 70,051 | 17.8753 | 1,252,183 | D |
| 20 Feb 2024 18:14 | DAWN | Day One Biopharmaceuticals Inc | BENDER JEREMY | CHIEF EXECUTIVE OFFICER | 16 Feb 2024 | Sale | 7,615 | 15.2481 | 116,114 | D |
| 17 Nov 2023 18:20 | DAWN | Day One Biopharmaceuticals Inc | BENDER JEREMY | Chief Executive Officer | 16 Nov 2023 | Sale | 3,107 | 11.69 | 36,321 | D |
| 17 Aug 2023 18:16 | DAWN | Day One Biopharmaceuticals Inc | BENDER JEREMY | Chief Executive Officer | 17 Aug 2023 | Sale | 2,996 | 13.86 | 41,525 | D |
| 17 May 2023 18:27 | DAWN | Day One Biopharmaceuticals Inc | BENDER JEREMY | Chief Executive Officer | 16 May 2023 | Sale | 3,104 | 13.1223 | 40,732 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)